Your account is not claimed yet. You can sign up with ORCID to claim your account.

Chien-Wei Su (C-W Su)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 29

Top Venues

Cancers

Liver international : official journal of the International Association for the Study of the Liver

Scientific reports

Hepatology (Baltimore, Md.)

National Yang-Ming University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

National Yang-Ming University

Taiwan

PHD :: Institute of Clinical medicine

Publications

Wei-Yu Kao, Elise Chia-Hui Tan, Hsin-Lun Lee, Yi-Hsiang Huang, Teh-Ia Huo, Chun-Chao Chang, Jeng-Fong Chiou, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su
Entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy. Alimentary pharmacology & therapeutics (2023)
Jia-I Liao, Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo
Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade. Cancers 15 (3) (2023)
Jia-I Liao, Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo
Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade. Cancers 15 (3) (2023)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo
Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Cancers 15 (7) (2023)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo
A New Tumor Burden Score and Albumin-Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma. Cancers 14 (3) (2022)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo
Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score. Cancers 14 (17) (2022)
I-Cheng Lee, Pei-Chang Lee, Yee Chao, Chen-Ta Chi, Chi-Jung Wu, Yi-Ping Hung, Chien-Wei Su, Ming-Chih Hou, Yi-Hsiang Huang
Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment. Viruses 14 (11) (2022)
Chun-Yang Lee, Gar-Yang Chau, Cheng-Yi Wei, Yee Chao, Yi-Hsiang Huang, Teh-Ia Huo, Ming-Chih Hou, Yu-Hui Su, Jaw-Ching Wu, Chien-Wei Su
Surgical resection could provide better outcomes for patients with hepatocellular carcinoma and tumor rupture. Scientific reports 12 (1) (2022)
I-Cheng Lee, Keng-Hsin Lan, Chien-Wei Su, Chung-Pin Li, Yee Chao, Han-Chieh Lin, Ming-Chih Hou, Yi-Hsiang Huang
Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy. International journal of molecular sciences 23 (19) (2022)
Wei-Yu Kao, Chien-Wei Su
Outcomes of atezolizumab and bevacizumab for hepatocellular carcinoma: Does age matter? Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
Yung-Sheng Chang, Chien-Wei Su, San-Chi Chen, Yen-Ying Chen, Yuh-Jin Liang, Jaw-Ching Wu
Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of Resistance. Cells 11 (4) (2022)
Yuh-Jin Liang, Wei Teng, Chih-Li Chen, Cheng-Pu Sun, Rui-Dung Teng, Yen-Hua Huang, Kung-Hao Liang, Yi-Wen Chen, Chung-Chih Lin, Chien-Wei Su, Mi-Hua Tao, Jaw-Ching Wu
Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development. Hepatology (Baltimore, Md.) 74 (2) (2021)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Chih-Chieh Ko, Yi-Hsiang Huang, Chien-Wei Su, Rheun-Chuan Lee, Ping-Hsing Tsai, Ming-Chih Hou, Teh-Ia Huo
Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Journal of gastroenterology and hepatology 36 (11) (2021)
Chen-Ta Chi, I-Cheng Lee, Rheun-Chuan Lee, Ya-Wen Hung, Chien-Wei Su, Ming-Chih Hou, Yee Chao, Yi-Hsiang Huang
Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection. Cancers 13 (17) (2021)
Wei Teng, Yen-Chun Liu, Wen-Juei Jeng, Chien-Wei Su
Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients. Cancers 13 (7) (2021)
Cheng-Yi Wei, Gar-Yang Chau, Ping-Hsien Chen, Chien-An Liu, Yi-Hsiang Huang, Teh-Ia Huo, Ming-Chih Hou, Han-Chieh Lin, Yu-Hui Su, Jaw-Ching Wu, Chien-Wei Su
A comparison of prognoses between surgical resection and radiofrequency ablation therapy for patients with hepatocellular carcinoma and esophagogastric varices. Scientific reports 10 (1) (2020)
Wei-Yu Kao, Elise Chia-Hui Tan, Chien-Wei Su
Reply. Hepatology (Baltimore, Md.) 70 (1) (2020)
Shu-Yein Ho, Chia-Yang Hsu, Po-Hong Liu, Chih-Chieh Ko, Yi-Hsiang Huang, Chien-Wei Su, Rheun-Chuan Lee, Ming-Chih Hou, Teh-Ia Huo
Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade. Cancers 12 (5) (2020)
Po-Hong Liu, Chia-Yang Hsu, Chien-Wei Su, Yi-Hsiang Huang, Ming-Chih Hou, Nicole E Rich, Naoto Fujiwara, Yujin Hoshida, Amit G Singal, Teh-Ia Huo
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 40 (10) (2020)
Pei-Chang Lee, Yi-You Chiou, Nai-Chi Chiu, Ping-Hsien Chen, Chien-An Liu, Wei-Yu Kao, Teh-Ia Huo, Yi-Hsiang Huang, Ming-Chih Hou, Han-Chieh Lin, Jaw-Ching Wu, Chien-Wei Su
Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation. Scientific reports 10 (1) (2020)
W-Y Kao, Chien-Wei Su
Letter: the role of direct-acting anti-virals in determining the risk of hepatocellular carcinoma development in patients with hepatitis C virus-induced cirrhosis. Alimentary pharmacology & therapeutics 47 (8) (2019)
Wei-Yu Kao, Chien-Wei Su, Elise Chia-Hui Tan, Pei-Chang Lee, Ping-Hsien Chen, Jui-Hsiang Tang, Yi-Hsiang Huang, Teh-Ia Huo, Chun-Chao Chang, Ming-Chih Hou, Han-Chieh Lin, Jaw-Ching Wu
Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C. Hepatology (Baltimore, Md.) 69 (3) (2019)
Zhong-Liang Su, Chien-Wei Su, Yi-Luen Huang, Wan-Yu Yang, Bonifasius Putera Sampurna, Toru Ouchi, Kuan-Lin Lee, Chen-Sheng Wu, Horng-Dar Wang, Chiou-Hwa Yuh
A Novel AURKA Mutant-Induced Early-Onset Severe Hepatocarcinogenesis Greater than Wild-Type via Activating Different Pathways in Zebrafish. Cancers 11 (7) (2019)
I-Cheng Lee, Ya-Wen Hung, Chien-An Liu, Rheun-Chuan Lee, Chien-Wei Su, Teh-Ia Huo, Chung-Pin Li, Yee Chao, Han-Chieh Lin, Ming-Chih Hou, Yi-Hsiang Huang
A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 39 (9) (2019)
Shen-Yung Wang, Chih-Li Chen, Yu-Chen Hu, Yi Chi, Yen-Hua Huang, Chien-Wei Su, Wen-Juei Jeng, Yuh-Jin Liang, Jaw-Ching Wu
High Expression of MicroRNA-196a is Associated with Progression of Hepatocellular Carcinoma in Younger Patients. Cancers 11 (10) (2019)
Shu-Yein Ho, Chia-Yang Hsu, Po-Hong Liu, Cheng-Yuan Hsia, Hao-Jan Lei, Yi-Hsiang Huang, Chih-Chieh Ko, Chien-Wei Su, Rheun-Chuan Lee, Ming-Chih Hou, Teh-Ia Huo
Albumin-bilirubin grade-based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 40 (1) (2019)
Chih-Li Chen, Yu-Shuen Tsai, Yen-Hua Huang, Yuh-Jin Liang, Ya-Yun Sun, Chien-Wei Su, Gar-Yang Chau, Yi-Chen Yeh, Yung-Sheng Chang, Jui-Ting Hu, Jaw-Ching Wu
Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial-Mesenchymal Transition Regulators and Stemness Genes. Hepatology communications 2 (11) (2018)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Chien-Wei Su, Yi-Jhen He, Yun-Hsuan Lee, Yi-Hsiang Huang, Ming-Chih Hou, Teh-Ia Huo
Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma. Scientific reports 8 (1) (2018)
Yuan-Lung Cheng, Yuan-Jen Wang, Keng-Hsin Lan, Teh-Ia Huo, Yi-Hsiang Huang, Chien-Wei Su, Wei-Yao Hsieh, Ming-Chih Hou, Han-Chieh Lin, Fa-Yauh Lee, Jaw-Ching Wu, Shou-Dong Lee
Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease. Gastroenterology research and practice 2017 (2017)

Chien-Wei Su.css-eqlu8i{font-size:small;padding-left:4px;} (C-W Su)

Publication Activity (10 Years)

Top Topics

Top Venues

Chien-Wei Su (C-W Su)